GERAGHTY JAMES A 4
4 · PIERIS PHARMACEUTICALS, INC. · Filed Oct 28, 2024
Insider Transaction Report
Form 4
GERAGHTY JAMES A
Director
Transactions
- Purchase
Series F Preferred Stock, par value $0.001 per share
2024-08-07$1.00/sh+1$1→ 1 total
Footnotes (1)
- [F1]On August 7, 2024, the Reporting Person purchased one (1) share of Series F Preferred Stock, par value $0.001 per share (the "Preferred Stock"), of Pieris Pharmaceuticals, Inc. (the "Issuer") from the Issuer for cash consideration of $1.00. The Preferred Stock has the rights, preferences, privileges and restrictions set forth in the Certificate of Designation of Series F Preferred Stock filed by the Issuer with the Nevada Secretary of State on August 7, 2024 (the "Series F COD"), including the right to have 25,000,000 votes and to vote together with the outstanding shares of the Issuer's common stock as a single class exclusively with respect to such voting proposals defined in the Series F COD.